A PLACEBO-CONTROLLED DOUBLE-BLIND-STUDY OF EPALRESTAT (ONO-2235) IN PATIENTS WITH DIABETIC NEUROPATHY

被引：20
|
作者：
GOTO, Y [1 ]
HOTTA, N [1 ]
SHIGETA, Y [1 ]
SAKAMOTO, N [1 ]
KITO, S [1 ]
MATSUOKA, K [1 ]
TAKAHASHI, A [1 ]
KIKKAWA, R [1 ]
SAKUMA, A [1 ]
机构：
[1] NAGOYA UNIV,SCH MED,DEPT INTERNAL MED 3,65 TSURUMAI CHO,SHOWA KU,NAGOYA,AICHI 466,JAPAN
来源：
DIABETIC MEDICINE | 1993年 / 10卷 / 05期
关键词：
ALDOSE REDUCTASE INHIBITOR; CLINICAL TRIALS; DIABETIC NEUROPATHY; EPALRESTAT; HEMOGLOBIN A1C; NERVE CONDUCTION VELOCITY;
D O I：
10.1111/j.1464-5491.1993.tb00197.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：S39 / S43
页数：5
相关论文
共 50 条
  • [21] Oral Alpha Lipoic Acid Treatment for Symptomatic Diabetic Peripheral Neuropathy: A Randomized Double-Blinded Placebo-Controlled Study
    El-Nahas, Mamdouh R.
    Elkannishy, Ghada
    Abdelhafez, Hala
    Elkhamisy, Enas T.
    El-Sehrawy, Amr A.
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2020, 20 (09) : 1531 - 1534
  • [22] Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials
    Thienel, U
    Neto, W
    Schwabe, SK
    Vijapurkar, U
    ACTA NEUROLOGICA SCANDINAVICA, 2004, 110 (04): : 221 - 231
  • [23] Levetiracetam in primary orthostatic tremor: A double-blind placebo-controlled crossover study
    Hellriegel, Helge
    Raethjen, Jan
    Deuschl, G.
    Volkmann, Jens
    MOVEMENT DISORDERS, 2011, 26 (13) : 2431 - 2434
  • [24] Galcanezumab in chronic migraine The randomized, double-blind, placebo-controlled REGAIN study
    Detke, Holland C.
    Goadsby, Peter J.
    Wang, Shufang
    Friedman, Deborah I.
    Selzler, Katherine J.
    Aurora, Sheena K.
    NEUROLOGY, 2018, 91 (24) : E2211 - E2221
  • [25] Multicenter, double-blind, placebo-controlled study of the use of filgrastim in patients hospitalized with pneumonia and severe sepsis
    Root, RK
    Lodato, RF
    Patrick, W
    Cade, JF
    Fotheringham, N
    Milwee, S
    Vincent, JL
    Torres, A
    Rello, J
    Nelson, S
    CRITICAL CARE MEDICINE, 2003, 31 (02) : 367 - 373
  • [26] GABAPENTIN (NEURONTIN) AS ADD-ON THERAPY IN PATIENTS WITH PARTIAL SEIZURES - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    ANHUT, H
    ASHMAN, P
    FEUERSTEIN, TJ
    SAUERMANN, W
    SAUNDERS, M
    SCHMIDT, B
    BAUER, G
    DEISENHAMMER, E
    KLINGLER, D
    MAMOLI, B
    GRAF, M
    DANTA, G
    BERKOVIC, S
    VAJDA, F
    BUCHANAN, N
    SCHAPEL, G
    BLACK, A
    BAJADA, S
    DEBARSY, T
    LATERRE, C
    VANZANDIJCKE, M
    MCLACHLAN, RS
    PURVES, SJ
    LEE, MA
    BRUNI, J
    GAWEL, M
    HOLTLARSEN, B
    WERDELIN, L
    DALBY, MA
    IIVANAINEN, MV
    GIROUD, M
    LECLERCQ, E
    REMY, C
    SALLOU, C
    RICHENS, A
    BILL, PLA
    EPILEPSIA, 1994, 35 (04) : 795 - 801
  • [27] Treatment with benfotiamine in patients with diabetic sensorimotor polyneuropathy: A double-blind, randomized, placebo-controlled, parallel group pilot study over 12 months
    Stirban, Ovidiu Alin
    Zeller-Stefan, Helga
    Schumacher, Jochen
    Gaus, Wilhelm
    Ziegler, Dan
    Schuerholz, Thomas
    Pop-Busui, Rodica
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2020, 34 (12)
  • [28] Relief of painful diabetic peripheral neuropathy with pregabalin: A randomized, placebo-controlled trial
    Richter, RW
    Portenoy, R
    Sharma, U
    Lamoreaux, L
    Bockbrader, H
    Knapp, LE
    JOURNAL OF PAIN, 2005, 6 (04) : 253 - 260
  • [29] Assessments of Suicidality in Double-Blind, Placebo-Controlled Trials of Ziprasidone
    Karayal, Onur N.
    Anway, Susan D.
    Batzar, Evan
    Vanderburg, Douglas G.
    JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (03) : 367 - 375
  • [30] Efficacy of naproxen in patients with sciatica: multicenter, randomized, double-blind, placebo-controlled trial
    Grovle, Lars
    Hasvik, Eivind
    Holst, Rene
    Saetre, Anders
    Brox, Jens Ivar
    Mathiassen, Stale
    Myhre, Kjersti
    Holmgard, Thor Einar
    Haugen, Anne Julsrud
    PAIN, 2024, 165 (11) : 2606 - 2614
12345